| Literature DB >> 28415997 |
Xue Mei1,2,3, Hao-Xun Wang4, Jian-Sheng Li5,6, Xiao-Hui Liu1, Xiao-Fan Lu2,3, Ya Li2,3,7, Wei-Yu Zhang2,3,7, Yan-Ge Tian2,3.
Abstract
BACKGROUND: Dusuqing granules (DSQ) have been used in the treatment of bacterial pneumonia clinically, with remarkable benefits. This study was initiated to explore the effects of DSQ on pulmonary inflammation by regulating nuclear factor (NF)-κB/mitogen-activated protein kinase (MAPK) signaling in bacterial pneumonia rats.Entities:
Keywords: Dusuqing granules; Klebsiella pneumoniae pneumonia; NF-κB/MAPK pathway; Traditional Chinese medicine; inflammation
Mesh:
Substances:
Year: 2017 PMID: 28415997 PMCID: PMC5392945 DOI: 10.1186/s12906-017-1736-x
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Lung Water Content in each group (mean ± SD)
| Group | N | Lung water content |
|---|---|---|
| control | 14 | 62.30 ± 1.44 |
| model | 11 | 94.06 ± 2.20** |
| DSQ | 13 | 75.86 ±1.11##▲▲ |
| LVX | 13 | 80.80 ± 0.70## |
Note: P<0.01 vs. control group; ## P<0.01 vs. model group; ▲▲ P<0.01 vs. LVX group
Fig. 1Pulmonary histomorphology in each group (H&E stained). (a) control group (b) model group (c) DSQ group; (d) LVX group. 1: alveolar congestion, 2: hemorrhage, 3: infiltration or aggregation of neutrophils, 4: thickness of alveolar wall (B)
Lung Injury Score (mean ± SD)
| Group | N | Score |
|---|---|---|
| control | 14 | 1.50±0.84 |
| model | 11 | 12.17±0.75** |
| DSQ | 13 | 8.17±0.75## |
| LVX | 13 | 8.33±0.82## |
Note: P<0.01 vs. control group; ## P<0.01 vs. model group
WBC population and PMN percent in peripheral blood in each group (mean ± SD)
| Group | N | WBC (×109/L) | PMN (%) |
|---|---|---|---|
| control | 14 | 6.38±1.23 | 24.22±5.11 |
| model | 11 | 13.52±2.86** | 56.24±6.37** |
| DSQ | 13 | 8.60±2.86## | 37.25±4.22## |
| LVX | 13 | 9.29±1.80## | 35.44±6.42## |
Note: P<0.01 vs. control group; ## P<0.01 vs. model group
WBC and PMN populations in bronchoalveolar lavage fluid in each group (mean ± SD)
| Group | N | WBC (×106/L) | PMN (×106/L) |
|---|---|---|---|
| control | 14 | 17.14±2.29 | 8.82±2.07 |
| model | 11 | 24.45±4.71** | 16.64±2.75** |
| DSQ | 13 | 21.36±3.76# | 13.65±3.17# |
| LVX | 13 | 20.84±3.34# | 13.95±3.16# |
Note: P<0.01 vs. control group; ## P<0.01 vs. model group
Fig. 2Levels of IL-1β, IL-6, MCP-1 and MIP-2 in the lungs in control, model, DSQ and LVX groups P<0.01 vs. control group; ## P<0.01 vs. model group; ▲ P<0.05 vs. LVX group. Values are expressed as mean ± S.D., one-way ANOVA
Fig. 3Expressions of NF-κB mRNA in the lungs in control, model, Dusuqing and Levofioxacin P<0.01 vs. control group; # P<0.05 vs. model group;. Values are expressed as mean ± S.D., one-way ANOVA
Fig. 4Phosphorylation of P38MAPK, JNK and ERK1/2 in the lungs in control, model, DSQ and LVX groups P<0.01 vs. control group; # P<0.05, ## P<0.01 vs. model group. Values are expressed as mean ± S.D., one-way ANOVA